ReviewPharmaceuticals (Basel, Switzerland)2023
Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria.
Katelyn E Madigan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.